Tagged with Researc

France Dr. Denis Comet, President of AFCRO (the French Association of CROs), talks about the evolution of the clinical research environment in France and the new government actions aimed at speeding up the clinical trial process.   Didier Genot from France Biotech told us that France has lost competitiveness when it…

Algeria Dr. Zoubir Harrat heads the Institut Pasteur d’Algérie (IPA), after having spent most of his career with the institution. He talks of the importance to prepare for the healthcare challenges of the future, and how the only way to achieve this is through collaboration and training of future generations.  …

Hong Kong Professor Justin Wu, chief operating officer of the Chinese University of Hong Kong (CUHK) Medical Center, shares his professional background and interest in gastroenterology, his insights into the research and commercialization environment in Hong Kong, and his hope for government, industry and academia to work together to propel Hong Kong…

Spain Josep Taberno MD PhD, director of VHIO, introduces the important work being conducted by the cancer institute in Spain as well as emerging trends in oncology. Can you tell us about VHIO? “ The complexities in cancer treatment and care are myriad. That said, I firmly believe that we can…

Turkey Mahmut Gümüş, president of the Turkish Society of Medical Oncology, paints a descriptive picture of the oncology situation in the country, with the looming epidemiological shift set to transform the healthcare sector. However, he has high hopes that the country will continue to prioritize oncology as a key therapeutic area…

UK One notable quirk of the British life sciences ecosystem is the importance of its not-for-profit sector. Indeed, in 2017, UK charities poured GBP 1.6 billion (USD 2.1 billion) into medical research; more than both the Medical Research Council (MRC) and the National Institute for Health Research (NIHR). Simon Gillespie, chief…

Spain Ricardo Martinez Murillo, director of the Cajal Institute – a neuroscience research center assigned to the Spanish Research Council (CSIC) and the oldest neurobiology research center in Spain – discusses recent breakthroughs in the field of neuroscience and highlights how better facilities and resources are paramount to making Spain a…

UK Chris Molloy, chief executive of the Medicines Discovery Catapult (MDC), discusses its role within the UK as a center for applied medical R&D and the future of the country’s drug discovery profile post-Brexit.  Could you please start by introducing the MDC? “We believe that the future is going to be…

Pharma While the automotive and electronics industries, among others, have been relatively fast in adopting robotics, pharma has been lagging behind. However, as the technology available becomes more advanced, flexible and affordable, robotics now stands as a pivotal element to helping pharmaceutical companies reduce costs and increase efficiency, notably in the…

Europe The top spenders on pharma R&D in Europe for 2015 were Switzerland – which spent over EUR 6.5 billion – followed by Germany – which spent EUR 6.2 billion – and the UK – which spent EUR 5.8 billion.

China As Professor of Neuroscience and Pain Medicine and director of the center for pain medicine at Southern University of Science and Technology (SUSTech) since 2016, Dr. Xue-jun Song explains the reasons he came back to China and decided to settle in Shenzhen. In this exclusive interview, he shares the advantages…

Spain Mariano Esteban Rodriguez, president of the Royal Academy of Pharmacy of Spain (RANF) and of the Institute of Spain (that integrates the 10 Royal Academies), discusses his current research interests in the field of virology as well his role within RANF, whose mission is to utilize the academy’s centenar expertise…